Vanguard Portfolio Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316M Buy
2,312,825
+7,731
+0.3% +$950K 0.01% 952
2026
Q1
$272M Buy
+2,305,094
New +$322M 0.01% 960

Other funds holding RGEN

Vanguard Portfolio Management's RGEN Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Repligen (RGEN) stake by 0.34% in Q2 2026, buying an estimated $950K and bringing the position to 2,312,825 shares worth $316M. The position accounts for 0.01% of the portfolio, ranked #952.

Vanguard Portfolio Management first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Vanguard Portfolio Management held 2,312,825 shares of Repligen worth $316M as of Q2 2026.
  • Vanguard Portfolio Management bought 7,731 Repligen shares in Q2 2026, an estimated $950K.
  • Repligen made up 0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #952 holding.
  • Vanguard Portfolio Management first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.